Integrated Core Strategies (US) LLC 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-28 4:00 pm Sale | 2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Integrated Core Strategies (US) LLC | 1,994,503 3.500% | -954,373 (-32.36%) | Filing |
| 2024-11-01 4:05 pm Purchase | 2024-10-28 | 13G | Astria Therapeutics, Inc. ATXS | Integrated Core Strategies (US) LLC | 2,948,876 5.200% | 2,948,876 (New Position) | Filing |